Lixte Biotechnology Holdings Inc (LIXT)
1.64
+0.12
(+7.89%)
USD |
NASDAQ |
Nov 22, 13:33
Lixte Biotechnology Holdings Enterprise Value: 5.281M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 5.281M |
| November 20, 2024 | 5.214M |
| November 19, 2024 | 5.304M |
| November 18, 2024 | 5.439M |
| November 15, 2024 | 5.506M |
| November 14, 2024 | 5.461M |
| November 13, 2024 | 5.551M |
| November 12, 2024 | 5.641M |
| November 11, 2024 | 5.574M |
| November 08, 2024 | 5.664M |
| November 07, 2024 | 5.461M |
| November 06, 2024 | 5.934M |
| November 05, 2024 | 6.114M |
| November 04, 2024 | 6.248M |
| November 01, 2024 | 6.406M |
| October 31, 2024 | 6.608M |
| October 30, 2024 | 6.653M |
| October 29, 2024 | 6.541M |
| October 28, 2024 | 4.809M |
| October 25, 2024 | 5.461M |
| October 24, 2024 | 5.461M |
| October 23, 2024 | 6.181M |
| October 22, 2024 | 6.361M |
| October 21, 2024 | 6.181M |
| October 18, 2024 | 6.113M |
| Date | Value |
|---|---|
| October 17, 2024 | 6.136M |
| October 16, 2024 | 5.823M |
| October 15, 2024 | 5.911M |
| October 14, 2024 | 5.844M |
| October 11, 2024 | 6.046M |
| October 10, 2024 | 5.956M |
| October 09, 2024 | 5.866M |
| October 08, 2024 | 5.866M |
| October 07, 2024 | 5.956M |
| October 04, 2024 | 6.024M |
| October 03, 2024 | 5.911M |
| October 02, 2024 | 6.114M |
| October 01, 2024 | 6.069M |
| September 30, 2024 | 6.069M |
| September 27, 2024 | 5.194M |
| September 26, 2024 | 5.088M |
| September 25, 2024 | 5.021M |
| September 24, 2024 | 4.976M |
| September 23, 2024 | 5.044M |
| September 20, 2024 | 5.134M |
| September 19, 2024 | 5.044M |
| September 18, 2024 | 5.403M |
| September 17, 2024 | 5.718M |
| September 16, 2024 | 5.493M |
| September 13, 2024 | 5.381M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.713M
Minimum
Dec 11 2023
82.18M
Maximum
Sep 08 2020
25.83M
Average
14.66M
Median
Enterprise Value Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | 3.326M |
| Soligenix Inc | 0.6511M |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.986M |
| Total Expenses (Quarterly) | 0.9833M |
| EPS Diluted (Quarterly) | -0.44 |
| Earnings Yield | -105.5% |